0001543053-17-000001.txt : 20170123
0001543053-17-000001.hdr.sgml : 20170123
20170123155704
ACCESSION NUMBER: 0001543053-17-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170120
FILED AS OF DATE: 20170123
DATE AS OF CHANGE: 20170123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harrelson Lori R.
CENTRAL INDEX KEY: 0001543053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 17541049
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27704
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-01-20
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001543053
Harrelson Lori R.
4233 TECHNOLOGY DRIVE
DURHAM
NC
27704
0
1
0
0
Vice President Finance
Common Stock
2017-01-20
4
A
0
3694
0
A
33699
D
Stock Option (right to buy)
5.05
2017-01-20
4
A
0
50000
0
A
2027-01-19
Common Stock
50000
50000
D
This option was granted on January 20, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018.
/s/ Lori R. Harrelson
2017-01-23